Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Shenzhen BinDeBio Ltd.
SpeciCare
Shenzhen BinDeBio Ltd.
National Cancer Institute (NCI)